Genetics and Syndromes Associated with Vascular Malformations

Pediatric Clinics of North America

Volumn 57, Issue 5, 2010, Pages 1111-1120

  Duffy, Kelly ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Genetic syndromes; Genetic testing; Overgrowth; Vascular anomaly; Vascular malformation

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TRANSCRIPTION FACTOR FOXC2; VASCULOTROPIN RECEPTOR 3;

ANGIOOSTEOHYPERTROPHY SYNDROME; ARTERIOVENOUS FISTULA; ARTERIOVENOUS MALFORMATION; AUTOSOMAL DOMINANT INHERITANCE; CAPILLARY MALFORMATION; CLOVES SYNDROME; CONGENITAL BLOOD VESSEL MALFORMATION; CUTANEOMUCOSAL VENOUS MALFORMATION; DISEASE ASSOCIATION; GENE MUTATION; GENETIC DISORDER; GENETIC SCREENING; GLOMUVENOUS MALFORMATION; HETEROZYGOSITY LOSS; HUMAN; LOSS OF FUNCTION MUTATION; LYMPHEDEMA; MILROY DISEASE; MOSAICISM; MULTIPLE CANCER; OSTEOCHONDROMA; PTEN HAMARTOMA TUMOR SYNDROME; RENDU OSLER WEBER DISEASE; REVIEW; SOMATIC MUTATION; STURGE WEBER SYNDROME; VEIN MALFORMATION; ARTERIOVENOUS MALFORMATIONS; BLOOD VESSEL; BRAIN ARTERIOVENOUS MALFORMATION; CAPILLARY; CONGENITAL DISORDER; GENETICS; LYMPH VESSEL; LYMPHATIC SYSTEM DISEASE; NEOVASCULARIZATION (PATHOLOGY); NEWBORN; SYNDROME; VASCULAR TUMOR;

ARTERIOVENOUS MALFORMATIONS; BLOOD VESSELS; CAPILLARIES; CONGENITAL ABNORMALITIES; HUMANS; INFANT, NEWBORN; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; LYMPHATIC ABNORMALITIES; LYMPHATIC VESSELS; NEOPLASMS, VASCULAR TISSUE; NEOVASCULARIZATION, PATHOLOGIC; SYNDROME;

EID: 77957268384     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2010.07.001     Document Type: Review

References (25)

1. Brouillard P., Vikkula M. Vascular malformations: localized defects in vascular morphogenesis. Clin Genet 2003, 63(5):340-351.
2. Happle R. Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J Am Acad Dermatol 1987, 16(4):899-906.
3. Mulliken J.B., Young A.E. Vascular birthmarks: hemangiomas and malformations 1998, Saunders, Philadelphia.
4. Boon L.M., Mulliken J.B., Vikkula M. RASA1: variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev 2005, 15(3):265-269.
5. Brouillard P., Vikkula M. Genetic causes of vascular malformations. Hum Mol Genet 2007, 16(Spec No. 2):R140-R149.
6. Eerola I., Boon L.M., Mulliken J.B., et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 2003, 73(6):1240-1249.
7. Revencu N., Boon L.M., Mulliken J.B., et al. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat 2008, 29(7):959-965.
8. Labauge P., Enjolras O., Bonerandi J.J., et al. An association between autosomal dominant cerebral cavernomas and a distinctive hyperkeratotic cutaneous vascular malformation in 4 families. Ann Neurol 1999, 45(2):250-254.
9. Eerola I., Plate K.H., Spiegel R., et al. KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation. Hum Mol Genet 2000, 9(9):1351-1355.
10. Laberge-le Couteulx S., Jung H.H., Labauge P., et al. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 1999, 23(2):189-193.
11. Sahoo T., Johnson E.W., Thomas J.W., et al. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet 1999, 8(12):2325-2333.
12. Liquori C.L., Berg M.J., Siegel A.M., et al. Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 2003, 73(6):1459-1464.
13. Bergametti F., Denier C., Labauge P., et al. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet 2005, 76(1):42-51.
14. Liquori C.L., Berg M.J., Squitieri F., et al. Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus. Hum Mutat 2006, 27(1):118.
15. Kehrer-Sawatzki H., Wilda M., Braun V.M., et al. Mutation and expression analysis of the KRIT1 gene associated with cerebral cavernous malformations (CCM1). Acta Neuropathol 2002, 104(3):231-240.
16. Gault J., Shenkar R., Recksiek P., et al. Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke 2005, 36(4):872-874.
17. Vikkula M., Boon L.M., Carraway K.L., et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 1996, 87(7):1181-1190.
18. Limaye N., Wouters V., Uebelhoer M., et al. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet 2009, 41(1):118-124.
19. Pagon RA, Bird TC, Dolan CR, et al, editors. GeneReviews [internet]. Seattle (WA): University of Washington; 1993-2008.
20. Calvert J.T., Riney T.J., Kontos C.D., et al. Allelic and locus heterogeneity in inherited venous malformations. Hum Mol Genet 1999, 8(7):1279-1289.
21. Blei F. Congenital lymphatic malformations. Ann N Y Acad Sci 2008, 1131:185-194.
22. McAllister K.A., Grogg K.M., Johnson D.W., et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994, 8(4):345-351.
23. Johnson D.W., Berg J.N., Baldwin M.A., et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996, 13(2):189-195.
24. Cole S.G., Begbie M.E., Wallace G.M., et al. A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 2005, 42(7):577-582.
25. Bayrak-Toydemir P., McDonald J., Akarsu N., et al. A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet A 2006, 140(20):2155-2162.